The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
about
Expression of the Bcl-3 proto-oncogene suppresses p53 activationCell Proliferation in NeuroblastomaNeuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosisPou5f1/Oct4 promotes cell survival via direct activation of mych expression during zebrafish gastrulationTherapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseasesFunctional Significance of Aurora Kinases-p53 Protein Family Interactions in CancerDickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastomaExploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy CombinationTherapeutic considerations for Mdm2: not just a one trick ponyGlobal MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation.Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data.MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.A novel and universal method for microRNA RT-qPCR data normalization.TGF-beta1-induced expression of human Mdm2 correlates with late-stage metastatic breast cancer.Increased MIR31HG lncRNA expression increases gefitinib resistance in non-small cell lung cancer cell lines through the EGFR/PI3K/AKT signaling pathway.MYC interacts with the human STAGA coactivator complex via multivalent contacts with the GCN5 and TRRAP subunits.The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplificationMdm2 links genotoxic stress and metabolism to p53.The p53 inhibitor MDM2 facilitates Sonic Hedgehog-mediated tumorigenesis and influences cerebellar foliationCo-localization of the oncogenic transcription factor MYCN and the DNA methyl binding protein MeCP2 at genomic sites in neuroblastoma.Myc proteins as therapeutic targets.Rapid establishment of a HEK 293 cell line expressing FVIII-BDD using AAV site-specific integration plasmids.Galectin-3 impairment of MYCN-dependent apoptosis-sensitive phenotype is antagonized by nutlin-3 in neuroblastoma cellsGenetic regulators of large-scale transcriptional signatures in cancer.MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines.Zinc Finger 280B regulates sGCα1 and p53 in prostate cancer cellsMDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cellsCrosstalk between MYCN and MDM2-p53 signal pathways regulates tumor cell growth and apoptosis in neuroblastomaFocal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.An unexpected role for caspase-2 in neuroblastoma.Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaSyrbactin Structural Analog TIR-199 Blocks Proteasome Activity and Induces Tumor Cell Death.Transcription factor NFAT1 activates the mdm2 oncogene independent of p53.Molecular mechanisms of MYCN-dependent apoptosis and the MDM2-p53 pathway: an Achille's heel to be exploited for the therapy of MYCN-amplified neuroblastoma.Redefining functional MYCN gene signatures in neuroblastoma.MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.Changes in the status of p53 affect drug sensitivity to thymidylate synthase (TS) inhibitors by altering TS levelsThe MYCN oncogene is a direct target of miR-34a.Cell survival signaling in neuroblastoma.
P2860
Q24300022-23B9DBF7-829B-49E8-8545-54A62A3DABB4Q26771708-DAFCDDF7-99CB-4765-869F-953150B1F863Q26774960-A500F128-41EB-4004-B8C2-A2FC9D02DA7DQ27314534-E094789A-2009-4785-A384-83DEC4B1D590Q27853237-842F3A4C-AE08-4232-9326-9AB105FB7462Q28071309-E5296D37-4F29-427F-9E22-DC639127B3DCQ28071615-721CD234-A2AD-4A24-B849-E926F1D37A08Q28117269-81A61524-51D9-4195-923B-826DB11E4AC0Q28118450-23649766-F53B-41FB-B609-AC3FD46A2935Q30380490-A6C72041-3525-45C3-B63B-4EA8DCFB7D97Q30974276-462AADD3-5CC2-44EA-90A6-F400068892B1Q31095310-1BC0B289-E140-4943-BB5C-E0C5FC61FA79Q33373153-A8E43AB6-DDD6-45EF-817B-4FAA14D51314Q33468633-38035924-E011-4D44-B156-A7ED007608EAQ33559621-A6E3EB83-537C-4145-9F15-AF20E110CA30Q33686369-1E1D1453-FBFA-4AB4-BCA2-418265D189C9Q33690584-EC3AF8E3-1AFF-4A11-B8C0-43F03D995109Q33761692-C7A63905-2780-4600-B750-BD2DE605D5E0Q33788018-BBD86191-79FB-404A-BF07-88A56F44C598Q33855554-C009CDFA-CA2B-45E9-9D80-4445B36FF930Q33952442-540542BB-7169-4C2D-8760-EF32109ED056Q33997741-11C2C16B-28AB-4F15-86FF-7220EB2E41C8Q34199436-7416922A-38F2-4259-8B7C-0E92A3B933B3Q34477775-91B9661A-AB4B-41F3-B0D0-786EBEA0D6DDQ34537800-8A8CA976-59F1-4FED-B7B6-DD64FE6AA20FQ34561690-FAA0D792-5DA7-4109-92A5-C21F57971660Q35043575-2EDF2FEE-6092-4AD8-A554-F86E795A5782Q35541790-92DB21DB-E067-4B4B-9984-CB1CA1707C62Q35556976-B60F50A9-4BA9-4AE8-88F1-65A36D50C62BQ35642231-0C99E26B-0D11-469A-98DB-A23FD935563FQ35679550-E860477A-2EFB-4572-B5F1-0723EF96949CQ35819646-EA88694F-C665-4D5C-9972-069720AB7A3BQ35933211-FBEFC4EE-F853-43F8-90B4-B834CA435C9AQ36216395-67741589-4591-4D59-B5DA-20FACBD5B6C4Q36313712-BBC8C846-A412-4804-A3F1-D526E7261E77Q36436759-BAEF62A3-695F-4F00-9E42-6355B32D0BC4Q36535291-C00372E8-9EFB-4417-8A25-3C0AD799E4B7Q36610029-06C697E7-0BF7-46E9-97AD-83EC85DC6665Q36926506-A6F3D2AC-B0E5-4FC2-BA88-BE0797A17104Q37010166-89B9306F-A6B4-4D3D-8D5A-9C4E06031DF6
P2860
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
@ast
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
@en
type
label
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
@ast
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
@en
prefLabel
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
@ast
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma.
@en
P2093
P2860
P356
P1476
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma
@en
P2093
Andrew Slack
Jason M Shohet
Roberto Tonelli
Zaowen Chen
P2860
P304
P356
10.1073/PNAS.0405495102
P407
P577
2005-01-11T00:00:00Z